INTRODUCTION
The understanding of human obesity has benefited greatly from advances in molecular genetics. In addition to the identification of many mechanistically illuminating, highly penetrant monogenic disorders, genome-wide association studies (GWAS) have identified multiple common genetic variants strongly associated with body mass index (BMI) (1) (2) (3) (4) (5) .
Many of these loci are within, or close to, genes which to date, have not been recognised to encode proteins with a role in the control of energy homeostasis. Of note, these genes show a strong preponderance to being highly expressed in the central nervous system, a finding which is congruent with the fact that monogenic disorders leading to obesity largely exert their effects through a disruption of the central control of appetite and energy balance (6) .
To fulfil the potential of these findings and to gain a better understanding of the underlying circuitry involved in the control of human energy balance, there is an imperative to bridge the gap between the identification of a variant as being associated with an adiposity phenotype and the understanding of how that variant actually influences energy balance. Murine models have proven to be essential in moving from statistical association to a fuller understanding of the biology of the genes potentially regulated by these genetic variants. For example, the robust correlation between BMI and polymorphisms in the human fat mass and obesityassociated (FTO) gene has since been followed by a number of rodent studies which have demonstrated a role for both FTO and its neighbouring genes in energy homeostasis and body composition (7) (8) (9) (10) (11) (12) (13) .
A strong association between increased BMI and a region of human chromosome 2, near to the gene TMEM18, has been repeatedly demonstrated in both adults and children (2, (14) (15) (16) (17) (18) .
TMEM18 encodes a small (140 amino acid) protein reported to be comprised of three transmembrane domains (19) . Like FTO, TMEM18 had not been recognised as having a role in energy homeostasis prior to its identification by GWAS and relatively little is known about its function, save that it is expressed in the brain (19) and may act as a DNA-binding protein (20) . The protein is highly conserved across several species (19) , Wiemerslage et. al. recently reported that loss of TMEM18 from insulin producing cells in Drosophila induces a metabolic state resembling type 2 diabetes (21) .
We have therefore undertaken a range of studies to determine whether TMEM18 plays a role in the control of energy balance in mammals.
RESULTS

Tmem18 expression within the hypothalamic paraventricular nucleus is nutritionally regulated.
We initially examined the expression pattern of Tmem18 in a range of murine tissues and two mouse hypothalamic cell lines (N-46 and GT1-7). In keeping with previous reports (19) ,
Tmem18 was widely expressed, with expression observed in several regions of the brain, in brown adipose tissue and in both hypothalamic cell lines ( Supplementary Fig 1) . To define the expression pattern within the hypothalamus, we used immunohistochemistry and found TMEM18 to be enriched within the paraventricular nucleus (PVN) and arcuate nucleus (ARC) ( Supplementary Fig 1) . Following this, we re-interrogated an existing data set arising from detailed transcriptomic analysis of distinct hypothalami nuclei we had previously acquired by laser capture microdissection (LCM) (22) . This was based on hypothalamic tissue from 3 groups of mice (ad lib fed, 48 hr fasted and fasted for 48 hrs with leptin administered throughout the fast). Within the ARC, microarray analysis showed no change in Tmem18 expression level across the three different nutritional states (data not shown). We therefore focused further on the PVN and repeated the fed, fasting, fasting plus leptin experiment in a second, separate cohort of mice, undertaking qPCR on laser capture PVN tissue. 48 hr fasting decreased PVN Tmem18 expression by 70% with leptin administration during the fast restoring expression back to fed levels (Fig 1) .
In a further set of animals, we undertook transcriptomic analysis (RNA Seq) of 4 distinct hypothalamic nuclei (arcuate, ventral medial, paraventricular and dorsal medial nuclei) in tissue acquired by LCM from wildtype mice who had been ad libitum fed or fasted for 24hrs (GEO accession number GSE96627). Analysis of control genes, in each of the nuclei, revealed expected results indicating that good microdissection had been achieved and the animals had responded appropriately to the fast ( Supplementary Fig 2) . Tmem18 expression was observed in all the four nuclei examined but differences in fed vs fast were only seen in the PVN (increased by ~30%) ( Supplementary Fig 3) . Of note, there was no significant change in fed vs fasted expression of vicinal genes (Sh3yl1, Snth2 and Acp1) in any of the 4 nuclei studied ( Supplementary Fig 4) . Thus, Tmem18 expression in the PVN appears to be altered during feeding and fasting in a biphasic manner with an initial modest rise followed by a more profound fall, which is dependent on a reduction in circulating leptin.
Loss of Tmem18 expression results in an increase in body mass
Knockout mice carrying mutant allele Tmem18 tm1a(EUCOMM)Wtsi (abbreviated to "Tmem18 tm1a ") were generated on a C57BL/6 genetic background as part of the European Conditional Mouse Mutagenesis Program (EUCOMM) (23) . The introduction of the allele results in targeted disruption of exon 2 of Tmem18. Generation of hypomorphic mice, as well as the disruption of neighboring genes, has previously been demonstrated using the "knockout first" strategy (24) (25) (26) (27) . We therefore determined the expression levels of Tmem18, and the genes that surround it on mouse chromosome 12, by Q-RT-PCR analysis in Tmem18 tm1a mice and their wildtype and heterozygous littermates. Data revealed a very low level of residual Tmem18 transcript within the hypothalamus of homozygous mice (2.1% ±1.4, Supplementary Figure   5A ), whilst heterozygous mice demonstrated a 50% decrease in transcript expression compared to Tmem18 +/+ (49% ±9, Supplementary Figure 5A ). Tmem18 was the only transcript at that locus to be altered by introduction of the allele (Supplementary Figure 5B) suggesting that there were no local 'off target' effects. The mice were viable with expected homozygous mutant offspring born from heterozygous crosses. WT and homozygous Tmem18 tm1a mice were weaned onto a diet of normal chow and weighed weekly until 16 weeks of age. Female Tmem18 tm1a homozygotes showed no differences in body weight or body composition compared to wildtype littermates (Supplementary Figs 6A, C and E). Male Tmem18 tm1a homozygotes, on normal chow, had significantly increased body weight by 14 weeks of age ( Fig 2A) . This increase in body weight was due to a significant increase in both fat and lean mass ( Fig 2C) . At 16 weeks of age male homozygotes weighed on average 1.9 g more than wildtype littermates and had both increased gonadal white adipose tissue (gWAT) and brown adipose tissue (BAT) ( Fig 2E) .
Male Tmem18 deficient mice fed a high fat diet become more obese because of an increase in food intake.
To determine the effects of a high fat diet on weight gain in Tmem18 deficient mice, WT and homozygous Tmem18 tm1a mice were weaned onto a normal chow diet at 3 weeks of age then switched to a 45% fat diet (HFD) at 8 weeks of age. All mice were weighed weekly from weaning until 16 weeks of age. Female Tmem18 tm1a homozygotes on a HFD showed no differences in body weight or body composition compared to wildtype littermates ( Supplementary Fig 6B, D and F). However, male Tmem18 tm1a homozygotes on a HFD displayed significantly increased body weight by 12 weeks of age ( Fig 2B) . This increase in body weight was a result of an increase in both fat and lean mass ( Fig 2D) . At 16 weeks of age male homozygotes on a HFD weighed ~4.1 g heavier than wildtype littermates and had both increased gWAT and BAT ( Fig 2F) . Food intake in these mice was assessed on two occasions, firstly over a 10-day period at 15 weeks of age whilst individually housed in home cages ( Fig   3A) , and secondly over the 72hr period at 16 weeks of ages when mice were being analyzed for energy expenditure ( Fig 3B) . On both occasions, Tmem18 deficient mice consumed significantly more energy than wildtype littermates. Interestingly, at the time of indirect calorimetry, Tmem18 deficient males fed a high fat diet displayed a significantly increased energy expenditure when compared to wildtype littermates (ANCOVA analysis with correction for body weight differences, *p=0.015, Figs 3C and 3D). Of note, Q-PCR analysis detected no significant difference in the expression of various markers of thermogenesis in brown adipose tissue between the two genotypes ( Fig 3E) and analysis of beam break data for the period when the mice were in the indirect calorimetry machine (72hrs) revealed no difference in activity levels between the two genotypes ( Fig 3F) . Thus, the increase in food intake (13.9%) in animals lacking Tmem18 was partially compensated for by a rise in energy expenditure (7.0%) which explains the modest increase in weight.
Overexpression of Tmem18 within the PVN reduces food intake and increased energy expenditure.
Having determined that Tmem18 expression in the PVN was altered by changes in nutritional state and that global loss of Tmem18 can affect food intake and energy expenditure, we used stereotactic injection of adeno-associated viral vector (AAV-T18) to manipulate expression of Tmem18 within the PVN and study subsequent effect on feeding behaviour and body weight.
We first undertook targeting studies using AAV over-expressing GFP in a cohort of 12 week old C57/BL6 male mice. Two weeks after unilateral injection, GFP expression was clearly visible within the targeted PVN ( Fig 4A) . Using identical serotype, volume and co-ordinates as the AAV-GFP experiments, we then performed bilateral injections of an AAV-Tmem18-cDNA into the PVN of 12 week old C57/BL6 male mice to increase Tmem18 expression specifically within this region of the hypothalamus. At the end of the experiment, mice were sacrificed and brains dissected. Micro-punches of the PVN were obtained from each brain and RNA extracted, cDNA synthesised and Q-RT-PCR performed as detailed in the methods section. Compared to control mice, mice who received vectors expressing Tmem18 cDNA had a significant two-fold increase in expression level ( Fig 4B) .
Our initial experiments sought to determine what impact overexpression of Tmem18 within the PVN would have upon energy balance so we followed a cohort of mice for 6 weeks after surgery, recording body weight weekly, measuring food intake in home cage at 2 weeks post-surgery and finally assessing both food intake and energy expenditure at the end of the 6 week period. In terms of absolute change in body weight, there was a significant difference in body weight gain at 2 weeks post-surgery ( Fig 4C) . By 6 weeks, mean weight gain in mice overexpressing Tmem18 was only 0.9 g compared to a 2.7 g in the control group injected with an AAV-GFP ( Fig 4C) . Expressed as a percentage weight gain from starting weight a post-surgery difference between groups was also evident at 2 weeks and remained statistically significant for the remainder of the study period ( Fig 4D) .
Analysis of food intake at 2 weeks post-surgery demonstrated AAV-T18 treated mice to have a significant reduction in food intake which was likely to have contributed to their reduction in weight gain ( Fig 4E) . Interestingly, when re-assessed at 6 weeks, this relative hypophagia appeared to have resolved with no difference in energy intake between genotypes ( Fig 4F) .
However, at 6 weeks post-surgery there was a significant difference in energy expenditure with AAV-T18 treated mice showing an increase compared to the control group ( Fig 4G, ANCOVA analysis with correction for body weight differences, *p=0.03).
Additionally, another group of mice (n=6) over-expressing Tmem18 were placed on a high fat diet immediately after stereotactic surgery. Again, in comparison to sham treated animals, mice over-expressing Tmem18 gained significantly less weight, with this difference becoming significant at three weeks post injection ( Fig 4H) . There was a trend for a reduction in energy intake at 2 weeks ( Fig 4I) and DEXA scanning at 6-weeks post-surgery showed a significant difference in both total and fat mass between the two groups of mice ( Fig 4J) .
TMEM18 contains four, not three, transmembrane domains
TMEM18 has been described to be a three transmembrane protein that localizes to the nuclear membrane, courtesy of a nuclear localization signal, and may be involved in transcriptional repression (19, 20) . To test this hypothesis, we first embarked on a deep phylogenetic analysis exploring sequence profile-to-profile homology (28) comprised a voltage-gated sodium channel from Caldalkalibacillus thermarum and an ion transport protein from Arcobacter butzleri (PDB identifiers 4bgn and 3rvy). Although their mutual phylogenetic distances are remote, they fold into a very similar structure and TMEM18 shares suggestive homology with their ion-transmitting domain. This region forms an oligomer consisting of two N-and C-terminal transmembrane helices pointing to the cytoplasm and two shorter inner helices fully embedded in the membrane. The conserved charged tip of their C-terminal helices is entirely outside the membrane and participates in the pore opening. It is highly probable that TMEM18 possesses a very similar topology and structure. Based on the homology to the C. thermarum channel, a very tentative model can be proposed for further testing. Figure 5A shows the modelled membrane topology and a putative 3D structure under the assumption that TMEM18 forms a tetramer similar to the A. butzleri channel (30) . As a nuclear membrane protein, it should expose both its termini to the cytoplasm and therefore would be comprised of four, rather than three, transmembrane domains. To test this experimentally we transfected Cos cells with a N-terminal FLAG-tagged Tmem18 construct then detected protein expression using either a FLAG antibody (to identify the N-terminus of the protein) or a TMEM18 antibody raised against C-terminus amino acids 120-134 (to identify the C-terminus of the protein). Protein expression was analyzed using two different detergents, TX100 that permeabilises all cellular membranes and digitonin, that 
TMEM18 is unlikely to directly regulate transcription
Little is known about the function of TMEM18. However, it has been suggested that it binds DNA and supresses transcription (20) . To test this hypothesis, we performed RNA-Seq analysis of hypothalami from wildtype and Tmem18 knockout male mice (ENA accession PRJEB13884).
Altogether, 27691 (27727 with non-zero total read count; 36 outliers per cooks Cutoff (31)) annotated genes had reads mapped in at least one sample and were used for differential expression analysis (average number of uniquely mapped reads per sample: 32.4x10-6 ± 2.04x10-6 SD). Interestingly, after adjustment for multiple testing, only Tmem18 was significantly differentially expressed within the hypothalami of the two genotypes (padj = 3.02
x 10-22, Fig 6A) . Q RT PCR analysis of Tmem18, and six additional genes with smallest (but not statistically significant) padj values confirmed the RNAseq data ( Fig 6A and 6B ), suggesting that TMEM18 is unlikely to be a global regulator of transcription as previously reported (20) .
TMEM18 interacts with two nuclear pore proteins, NDC1 and AAASs
We used the methods of affinity purification and mass spectrometry (32) to identify novel TMEM18 interacting partners. Either FLAG-tagged TMEM18 or empty FLAG vector were over expressed in HEK293 cells. Protein complexes were immunoprecipitated using a FLAG antibody and mass spectrometry analysis performed to detect proteins bound to TMEM18. This process identified 116 proteins pulled down in control cells expressing the empty FLAG vector, 221 proteins common to both the control and experimental group, and 244 proteins unique to cells expressing FLAG-TMEM18 (See Supplementary Table 1 for a list of all proteins identified as being pulled down by FLAG-TMEM18). Interestingly, three members of the nuclear pore complex, NDC1, AAAS, and NUP35/53 (33) showed high numbers of assigned spectra indicating a high abundance of these proteins after pulldown. Therefore, biomolecular immunofluorescence complementation (BiFC) assays were employed to confirm interactions between these proteins and Tmem18. Controls behaved as expected and showed that no YFP expression was seen if YN constructs were co-transfected with a YC-STOP plasmid ( Fig 7A) . YN-FLAG-NDC1 and YC-AAAS served as an appropriate positive control ( Fig 7B) as these proteins have been reported to interact previously (34, 35) . YFP expression could be detected in cells expressing YC-TMEM18 and either YN-FLAG-NDC1 or YN-FLAG-AAAS; but not YN-FLAG-NUP35 ( Fig 7C-G) . Positive BiFC protein-protein interactions were corroborated further by co-immunoprecipitation experiments using FLAG-TMEM18 and either GFP tagged NDC1 ( Fig 7H) or GFP tagged AAAS ( Fig 7I) .
DISCUSSION
Our data indicate that altering Tmem18 expression in mice, both globally and within the hypothalamus, can alter body weight. Male mice with a germline loss of Tmem18 have an increased body weight due to a significant increase in both fat and lean mass. This phenotype is more pronounced on a high fat diet, where weight gain is driven by hyperphagia. In contrast, overexpression of Tmem18 expression within the hypothalamic PVN can reduce food intake, increase energy expenditure and reduce both total body and fat mass.
The increased body weight phenotype of Tmem18 null mice was sexually dimorphic.
Sex-specific differences in metabolic studies focusing on body weight are not uncommon and have been seen, for example, after embryonic TrkB inhibition or with disruption of GABA receptor signalling in proopiomelanocortin neurons (36, 37) . In these reports and in our current study data, the mechanisms behind the sex-specific changes in body weight remain to be fully determined but the differences in circulating gonadal derived hormones remain, of course, a potential contributor. Indeed, the relevance of oestrogen in influencing the response to a dietary intervention was highlighted again in a study by Dakin et. al. in which oestradiol treatment to male mice fed a high-fat, high-sugar 'obesogenic' diet prevented increases in adipose tissue mass (38) .
Male mice on a high fat diet gained weight because of increased energy intake. Of note, data from indirect calorimetry also showed Tmem18 null mice to have a ~10% increase in energy expenditure compared to wild type mice, but as food intake was increased by ~30% the dominant drive was to caloric excess and weight gain. This could be considered an example of "diet induced thermogenesis", a state seen as an effect of a change to a higher calorie diet in which mice increase energy expenditure and food intake simultaneously (39) . The potential biological purpose and the tissues relevant to this phenomenon continue to be disputed (40) .
There is more agreement that the ambient temperature of a study can have a strongly qualitative effect on the outcome of metabolic studies (41) . Our studies were conducted under "standard" animal house conditions that can be considered a chronic thermal stress to mice. Future studies of energy expenditure in Tmem18 deficient mice living at thermoneutrality may be helpful in further understanding the role of this molecule in metabolic control.
When studying high fat fed male animals, in both genotypes food intake was higher in the home cage compared to that recorded in the calorimetry system. The difference in absolute food intake may reflect a degree of stress in a less familiar environment but we mitigated against this by allowing mice a period of acclimatisation in both the room and the cage type in which the calorimetry studies were performed.
In trying to determine the locus of action driving the effects of TMEM18 on body composition we chose to start within the PVN, an anatomical region enriched with neuronal populations involved in appetitive behaviour and energy expenditure (42) (43) (44) (45) (46) . In two distinct cohorts, one fed normal chow, another high fat diet, adult onset overexpression of Tmem18 in the PVN diminished body weight gain. There was also a reduction in food intake and when viewed with the hyperphagia seen in the Tmem18 null mice, our data suggest that Tmem18 expressing neurons in the PVN have a role in food intake. However, our data also indicate that Tmem18 is expressed within a number of other regions within the hypothalamus.
Further the nature of the different perturbations (germline loss in Tmem18 tm1a vs delivery of AAV via stereotactic injection) means that the PVN neuronal population which lost Tmem18 expression in the null mice may not be the same population that gained overexpression in the stereotactic-driven AAV study. We were unfortunately unsuccessful in our attempts to use siRNA and Cre to selectively knock down and/or delete Tmem18 in the PVN despite promising preliminary studies in vitro (data not shown). In the future, transgenic lines with specific anatomical Cre drivers (e.g. Sim1-Cre, Agrp-Cre) may be helpful to further delineate the role of Tmem18 in hypothalamic nuclei.
In recent years there have been several reports investigating Tmem18 expression within the brain and its link to obesity. Almen et al. reported that Tmem18 is expressed in tissues throughout the body and confirmed abundant Tmem18 expression in the hypothalamus (19) . Tmem18 in whole hypothalami from fasted mice (4 hours only) and from mice fed both standard chow and a high sucrose diet (47) . Again, expression levels in the hypothalamus were identical across these conditions although intriguingly in the rest of the brain excluding the hypothalamus, Tmem18 expression was some 8-fold higher in the fed group compared to the fasted group. Schmid et al. studied Tmem18 expression in obese Zucker diabetic fatty rats and again found the highest amounts of Tmem18 mRNA in the hypothalamus (48) . Thus, although several groups have also shown Tmem18 to be highly expressed within the hypothalamus, not all have reported it to be nutritionally regulated. However, the specific neuronal populations within the relatively heterogeneous PVN through which Tmem18 functions remain to be fully defined.
Our report presents interesting new data on the potential function of TMEM18. Previous reports have indicated that TMEM18 is highly conserved, has no family members, localizes at the nuclear membrane and that the C-terminus of the protein may be involved in the regulation of transcription. Whilst the localization of TMEM18 is not disputed we propose that a role for TMEM18 in transcriptional regulation is unlikely given our RNA-Seq data showing that the hypothalamic transcriptome of Tmem18 tm1a mice is not significantly different to that of wildtype littermates. Previous bioinformatic analysis had predicted a 3 transmembrane structure (19, 49) . However, our cellular experiments reveal that TMEM18 is in fact comprised of four transmembrane segments indicating that it is unlikely that the C-terminus is involved in binding DNA as earlier reported (20) . Instead we hypothesise that TMEM18 may be involved in the transport of molecules across the nuclear envelope. Pulldown experiments, corroborated by BiFC and IP studies have identified two novel binding partners for TMEM18 -NDC1 and AAAS/ALADIN. These proteins are two of the thirty NUPs that make up the nuclear pore complex (NPC) (50) . As NDC1 and AAAS have previously been reported to interact with one another (35) it is possible that TMEM18 is not interacting directly with both proteins. By enabling transport of molecules across the nuclear envelope, NUPs are involved in many fundamental cellular processes, consequently abnormal expression/function of these NUPs has been linked to various human diseases such as cancer, cardiovascular disorders, autoimmune disease and neurological defects (51) . Further investigation into the interaction of TMEM18 with members of the NPC will hopefully shed new light on the molecular function of TMEM18 and its role in obesity.
Prior to featuring in any GWAS, Tmem18 was initially identified in a bioinformatics screen investigating cis-regulatory motifs involved in translational control (52) and an additional screen searching for novel modulators of cell migration (49) . The association of single nucleotide polymorphisms (SNPs) near human TMEM18 with obesity was first reported by Willer et al. (2) and has since been identified by multiple GWAS (reviewed in (6)).
Undoubtedly, GWAS have produced much new data relevant to obesity. However, increasing knowledge about the association between genetic variants and the condition under investigation brings forth a series of challenges. The GWAS data alone cannot indicate which SNPs are causal nor which cell type or tissue is relevant. Further, many of the variants are located in non-coding regions of the genome giving no immediate clue to mechanism. All of these points are germane to the SNPs located near to TMEM18. SNP rs6548238 is, for example, greater than 30 kb downstream of TMEM18 and falls in a relative 'gene desert', lying over 300 kb from the next nearest genes (SNTG2 and FAM150B). Thus, although these loci have taken on the moniker of 'near to TMEM18', to date it has remained unclear whether these variants have any influence on the regulation of TMEM18 expression or function, or indeed if TMEM18 has a direct role in energy homeostasis.
Efforts to advance understanding from association to biologically relevant mechanisms have combined multiple techniques and evidence from several model platforms. For example, when investigating obesity associated noncoding sequences within FTO, Smemo used chromatin conformation capture techniques (CCST) to show a region of FTO directly interacts with, and forms part of the regulatory landscape of, the homeobox gene IRX3 (10) . They also reported that relevant SNPS were associated with expression of IRX3, but not FTO, in human brains. In a more recent study of obesity associated FTO variants, Claussnitzer combined chromatin capture technology, eQTL data and a powerful bioinformatics approach to report that these variants can reduce thermogenesis in human adipocytes (53) . However, given the clear evidence that the obesogenic FTO SNPs have a stringent and reproducible impact on aspects of human appetite (54) including directly measured food intake (55) coupled with the lack of evidence for any impact on human energy expenditure (56) , the physiological relevance of these latter observations must remain open to question.
Thus far our attempts to interrogate the region near TMEM18 through the examination of various gene expression databases shows no eQTL data relevant to these SNPs (data not shown). A brain tissue specific approach may prove more fruitful but unfortunately RNA expression data specifically from human hypothalamus linked to genotype is not a currently publicly available resource. The studies we have described have strengthened the candidacy of TMEM18 as, at least in part, the mediator of the association between genetic variation in this region of chromosome 2 and human adiposity, one of the strongest associations of a common variant with human obesity. Our work has also provided novel information about the topology and binding partners of this enigmatic protein associated with the nuclear pore complex. Metabolic phenotyping. Body weight measurements were recorded on a weekly basis. Food intake studies were carried out on single housed animals in home cages. Daily food intake was an average taken from 10 consecutive days. Body composition was determined using dual-energy x-ray absorptiometry (DEXA) (Lunar PIXImus2 mouse densitometer, General Electric Medical Systems, Fitchburg, WI). Any animal who did not remain weight stable did not proceed to calorimetry. Energy expenditure was determined using indirect calorimetry in a custom built monitoring system at 20 o C (Ideas Studio, Cambridge, UK). Activity was assessed by beam breaks. Beams were 1.25 cm apart and activity measurements were taken to be total beam breaks, rather than consecutive beam breaks. Any data from an animal whose weight changes in the calorimetry system were beyond those seen in the long-term home cage environment were excluded from analysis. At the end of the experiment animals were sacrificed and tissues collected for further analysis.
METHODS
Animals
Immunohistochemistry and histology. Animals were anesthetized with pentabarbitol (Dolethal) then transcardially perfused with 20 ml PBS followed by 40 ml 10% Formalin/PBS (Sigma). Brains were dissected out and incubated in 15% sucrose/10% Formalin overnight at 4 o C. Following cryoprotection in 30% sucrose/PBS, brains were frozen on dry-ice and stored at -80 o C overnight. Serial 35 μM sections were taken using a freezing microtome and mounted on glass slides (VWR).
Laser capture microdissection and Q-RT-PCR of fed and 48hr fasted mouse brains.
Laser-captured microdissection and total RNA isolation were carried out as previously described (22, 62) . (64) . The number of reads that mapped to each annotated gene was counted using the HTSeq (v.0.6.1) count function (HTSeq.scripts.count, mode intersection-nonempty). The DESeq2 package (v.1.9.29) (31) was used for differential gene expression analysis between mutant and wildtype mice, using the Benjamini-Hochberg procedure (to control for multiple testing, returning an adjusted p value (padj)). A significance cut-off of padj < 0.05 was used.
Quantitative-RT-PCR. Q-RT-PCR was performed on whole hypothalami and brown adipose tissue (BAT). Tissues were dissected from individual mice, snap frozen and stored at -80 o C until processed. RNA was extracted using TriSure (Bioline) and reverse transcribed using Il-Prom-II reverse transcription system (Promega) according to manufacturer's instructions.
To assess Tmem18 expression within the PVN following surgery micro-punches of the PVN from individual mice were obtained from fresh frozen brains. Accuracy of the micro-punches was confirmed with cresyl violet staining of the cryostat sections after nuclei removal. RNA was isolated from the micro-punch using the Qiagen RNeasy micro system and 50 ng of purified RNA were used in a random-primed first strand cDNA synthesis reaction, using the VILO reverse transcriptase kit (Invitrogen). Quantitative PCR reactions were performed in triplicate on an ABI 7900HT (Applied Biosystems) using ABI PCR master mix and commercially available Taqman probes, according to manufacturer's protocols. All Q-RT-PCR data was normalised to Gapdh expression.
Transient transfection and immunocytochemistry. Cos7 cells were plated on four-well glass chamber slides (Nalge Nunc International) at 25,000 cells/ml; 16 h later, each well was transfected with 500 ng of plasmid DNA using Lipofectamine (Thermo Fisher Scientific). After 48 h at 37 o C, cells were fixed in 3.7% formaldehyde with either 0.2% TritonX100 for 10 mins at RT or 40 ug/ml Digitonin for 10 mins at 4 o C. After washing in PBS, cells were incubated O/N at 4 o C with the appropriate primary antibody. The following morning, cells were washed in PBS and incubated with an appropriate secondary antibody conjugated to either a 488 or 594 fluorophore. After washing in PBS, coverslips were mounted using VectaShield hardset mounting media with DAPI (Vector Laboratories) and fluorescent cells detected using a Nikon Eclipse TE2000-U microscope. If colocalization of two proteins was being studied, before mounting with coverslips, cells were incubated with the second primary antibody at RT for 3hrs, washed in PBS then incubated with an appropriate secondary antibody conjugated to either a 488 or 594 fluorophore. Primary antibodies used were as follows: custom made rabbit-anti-mouseTmem18 antibody raised against amino acids 120-134; Rabbit Polyclonal Bioinformatic Analysis. TMEM18 orthologues (144 sequences) from OMA database (http://omabrowser.org) were aligned with Muscle (67) and submitted to HHpred searches (28) in all available microbial fungal and metazoan protein databases and collections of HMM profiles using MPI Toolkit suite (29) . The homology models were based on the HHpred alignments. The structures were displayed and examined with Protein Workshop Viewer (68) . The conserved C-terminus (~25 amino acids) is exposed to the cytoplasm and the upper four-helix domain is embedded in the membrane with its N-terminus pointing to the cytoplasm. The preceding sequence of~50 amino acids is exposed to the cytoplasm but cannot be modelled due to the lack of homology. (B-H) Overexpression of N-terminal FLAGtagged TMEM18 in COS cells treated with either TX-100 (permeabilises both plasma & nuclear membrane) or digitonin (permeabilises plasma membrane only). Lamin (B&C) and Calnexin (D&E) are shown as controls. TMEM18 expression was detected with either a FLAG antibody (red, F&G) or an antibody to the C-terminus of TMEM18 (green, H&I). 
